
08/09/2025
With the projected price increase of Mounjaro (a weight loss injection) of possibly 170%, we are revisiting a previous article discussing the ethics of weight-loss injections.
What are your thoughts?
https://jme.bmj.com/content/early/2025/03/20/jme-2024-110374
Journal of Medical Ethics (JME)
Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market. Manufactured by Novo Nordisk, semaglutide is the newest in a family of glucagon-like peptide-1 receptor agonists used most commonly to treat type II diabetes. To date, the results...